(3S,4S)-TERT-BUTYL 3,4-DIHYDROXYPYRROLIDINE-1-CARBOXYLATE, 95.0%, 10g

4,6-Diisopropylpyrimidin-5-amine, 98%, 5g

BENZNIDAZOLE, 95%, 250mg

(2-Aminopyrimidin-4-yl)dimethylphosphine oxide, 98%, 1g

ethyl 1-(2-cyano-4-nitrophenyl)piperidine-3-carboxylate, 250mg

2-Butanol, min. 98.5%, for synthesis, 25 l, plastic packaging.

DIMETHYL 2-(4-AMINOPHENYL)MALONATE, 95.0%, 250mg

5-Pyrimidinecarboxamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]-3-fluorophenyl]-3-(4-fluorophenyl)-1,2,3,4-tetrahydro-1-(1-methylethyl)-2,4-dioxo-, 98%, 10mg

5-chloro-3-(3-methoxyphenyl)-1,2,4-oxadiazole, 95.0%, 500mg

3-((4-chloro-3-(trifluoromethyl)phenyl)sulfonamido)benzoic acid, 95.0%, 1g

(S)-(-)-alpha,alpha-Diphenyl-2-pyrrolidinemethanol>98.0%(GC)(T)1g

(R)-3-((((9h-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(m-tolyl)propanoic acid, 95+%, 250mg

4-AMINO-3-BROMO-2-FLUOROPYRIDINE, 95.0%, 1g